Vaccine Study

download Vaccine Study

of 66

Transcript of Vaccine Study

  • 8/6/2019 Vaccine Study

    1/66

    Pace Environmental Law Review

    Volume 28Issue 2 Winter 2011

    Article 6

    5-10-2011

    Unanswered Questions from the Vaccine InjuryCompensation Program: A Review of

    Compensated Cases of Vaccine-Induced BrainInjuryMary HollandNYU School of Law, [email protected]

    Louis Conte

    Robert Krakow

    Lisa Colin

    This Article is brought to you for free and open access by the School of Law at DigitalCommons@Pace. It has been accepted for inclusion in Pace

    Environmental Law Review by an authorized administrator of DigitalCommons@Pace. For more information, please contact [email protected].

    Recommended CitationMary Holland, Louis Conte, Robert Krakow, and Lisa Colin, Unanswered Questions from the VaccineInjury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury, 28Pace Envtl. L. Rev. 480 (2011)

    Available at: http://digitalcommons.pace.edu/pelr/vol28/iss2/6

    http://digitalcommons.pace.edu/pelrhttp://digitalcommons.pace.edu/pelr/vol28http://digitalcommons.pace.edu/pelr/vol28/iss2http://digitalcommons.pace.edu/pelr/vol28/iss2http://digitalcommons.pace.edu/pelr/vol28/iss2/6mailto:[email protected]:[email protected]://digitalcommons.pace.edu/pelr/vol28/iss2/6http://digitalcommons.pace.edu/pelr/vol28/iss2http://digitalcommons.pace.edu/pelr/vol28http://digitalcommons.pace.edu/pelr
  • 8/6/2019 Vaccine Study

    2/66

    NDC 30

    4

    RTILE

    UNNSWERED QUESTIONS ROM THE

    VINE INJURY OMPENSTIONPRORM

    Review of ompensated ases of VaccineInduced rain Injury

    YNDUIS CNTT W ND ISCIN

    INTRODUTION

    Is the Vaccine Injury Compensation Program VICP ofthe US Court of Federal Claims a fair forum? This is not a

    trivial question as it is the only forum in which parents may

    bring claims for vaccine injury to their children Under the 196

    National Childhood Vaccine Injury ct 196 aw Congress

    created an administrative forum that it meant to ensure simple

    justice for children it gave the VICP original jurisdiction for all

    vaccine injury claims1 ecause almost all US children must

    ary olland esearch Scholar and Director of the raduate egal SkillsProgram NYU School of aw ouis Conte independent investigator andobert rakow and isa Colin attorneys in private practice Pace aw Schoolprovided significant research support for this study The authors thank formernvironmental aw Dean lexandra Dunn and law students Jillian Petrerayle Caffrey Sohad Jamal lison aplan eorgine ells Jonne onquilloisa atem llison azi and drienne Fortin The authors also thankvolunteers who worked under the direction of ouis Conte For purposes ofdisclosure obert rakow and isa Colin represent clients and have claims onbehalf of family members in the Vaccine Injury Compensation Program

    1 National Childhood Vaccine Injury ct of 196 42 USC aa-112 26 ll individuals injured by a vaccine administered after thedate of enactment of the legislation are required to go through the compensationprogram P N 99-9 at 196 reprinted in 196 USCCN644 644 fter filing in the program petitioners may reject program

    judgments or opt out of it to bring claims in state or federal court but initialclaims over 1 in damages must be made in the VICP Id at 12

  • 8/6/2019 Vaccine Study

    3/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    K>BO>O:MH:MM>G==:R:G=L %, A:L A:= : BQ>= ABLMHKR BG MA> >R>L H MA>

    :BEB>LHMA>O:=

    BMBLH MHLM BHKM:G MA:M MABL MKB;G:E KHOB=>L >BM:;E>MK>:M>GMMK:GL:K>GGAHA:O>

    MA>@K:O>BLHKMG>MH;>BGK>=;RMA>O>KRO:G=>=MH>>MA>A>:EMAR

    3ABE>LH>:K>GMLHO:=GLHKM>=MA>(:HO>KMB>:GRMH

    OB>BMBMA;BMM>K=BL:HBGM>GMXEK>:=R;RMA>B=ZL$$/ A:= K>== MA> @KHG=L HK K>LMBO> KR HK O:KO>KLHG= MKH;EBG@

    0A:M G@> ;>@:G BG A>G G>:KER BO> MAHL:G=

    :BEB>LBE>=>MBMBHGLBMAMA>%,KHEH@BK = :MBLX

    M MA> %,ZL @K>:M>LM G@> R>M E:R:A>:=

    &// &>+>/ %/;?3= *0%+*( *!03+.' "+. %))*%0%+*AMMBGB:MBHGBGHHK@O:K>BK>>GML E:LM OBLBM>= ">; KHOB=BG@ : L>:K EBLMH O:BK>>GMLHK G;RLM:M>

    /M:KMBG@ BG MA> E:M> ZL MA> K>>GL

    &// /1 KB> HK MA> *:MBHG:E :GM>K >M :E :LB /HKMBG@ ,>MBMBHG>KL K>L>BM O 3R>MA /M *H +@+36+,6/ +> AMM:>KBOB>;EB=K>OB>;KB>L=L,>MBMBHG>K*%:G=+K@L:MAM>LMBHGRH:K;:K:(H>"BLA>K;>HK>HG@K>LLBG 0A>K> BL ;BMM>K =BL:HBGM>GM :G= >KO:LBO> GA:BG>LL :HG@:K>GMLBMAMA>GMLMK:G=:=BGBLMK:MBHGHMA>O:HO>= MA> K>LMBHG H K>KR KH K>LB=:E L>BK>=BLHK=>KX BG ):K MA> K>L>BM :BER BG

  • 8/6/2019 Vaccine Study

    4/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    ;>@:GMHLRKHM %G:GGK>=>GM>=KH>=BG@MA>%,:M>= :G= +GB;L MBL ,KH>=BG@=A>:KBG@L>:GMMH;KBG@LMBMHMA>L>

    %, =BLBLL>= :EE MA> M>LM X :ELHKMA>">=>K:EBKE=:EEMA>=>OB>

    >LBM> ::K>GM =B=>:BGK>MA>LH:MBLX

    MA:MMA>%,K>>=BGMA>+GB;L MBL,KH>=BG@K>:EER=B>K>GMKHMA>LH>GA:EH:MARX:G=K>LB=:EL>BK>=BLHK=>KXMA:MMA>%,A:LGL:M>=;>HK>:G=LBG %LBMHLLB;E>MA>%, K>>=LH:MBLX;>H MA>AHM;MMHG E:;>E :G= GHM ;> H K>:E =B>K>GL BG BGKB>L HK>OB=>G

    0ABL K>EBBG:KR LM=R L@@>LML MA:M MA> %, A:L ;>>GGL:MBG@ L H O:GA:EH:MAR :G=

    K>LB=:E L>BK> =BLHK=>K :LLH= BMA :MBL LBG MA>BGMBHG H MA> KH@K: 0AKH@A MABLK>EBBG:KR LM=R MA>:MAHKL A:O> HG= >B@AMRMAK>> L H :MBL :HG@ MAHL>GL:M>= HK O:

    0ABL :LL>LL>GM H GL:M>= L LAHBG@ :G:LLHM>>G O:L GHMKHKM MH ;> LG %G GH :R =H>L BM >QE:BG LGMBBG G>LL:KBER G=>KBG> MA> K>:LHGBG@ H MA>

    => +GB;L MBL ,KH>=BG@ ;:L>= HG MA>LGMBBHKB>L :G= >=BOB=>G ;>HK> MA> %, *HK=H>L MABL :KMB A:O> :GRMABG@ MH L:R :;HM LM:M> LBG@>G>K:E

    0ABL BG=BG@K:BL>L G=:>GM:E>LMBHGL:;HM MA>BGM>@KBMR MK:GL:K>GLLHMABLHK

    3A:M MABL :KMB =H>L HBGM MH :K> G:GL>K>= >LMBHGL:;HM O: MA:M :>

  • 8/6/2019 Vaccine Study

    5/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    :KHQB:M>ER HG> BGHG>AG=K>=:G= M>GG+GMABLHBGM MABL LM=R LMKHG@ER L@@>LML MA> G>>= HK KMA>KHG@K>LLBHG:E :G= LGMBBLMB@:MBHG MH >QEHK> MA>

    :LLHM>>GO: BGM>@KBMR H MABL >=>K:EER:=BGBLM>K>= GL:MBHGKH@K:

    %G,:KM%>K>OB>MA>(:MA:M:M>=MA>%,:G=MA> +GB;L ;:

    >:KM>GMH$>:EMA:G=$:G/>KOBLZ$$/X#96381:G=:MM>MLMH@>MBGHK:MBHG:;HM:MBLKH GL:M>= L H O:M:BEL MA>;EBLA>= L BG MA> %, MA:M GHM> :MBL HK :MBLEB>LRMHL :G= BGHK:MBHG :;HM L>MME>= L :GB>LMBG@:MBLMA:M:K>GM:E@BO>KLA:O>=%M=BLLMA>

    L :G= BGL K>K>L>GM:MBO>>LMBHGG:BK> K>LHGL>L KH:K>GML :G= @BO>KL ,:KM %%% AB@AEB@AML G:GL>K>=>LMBHGL :>L K>G=:MBHGL :G= =K:L QKMLKH : "K>>=H H %GHK:MBHG .>>LM : EBLM H K>OBHLER;EBLA>=:KMBL>O:E:MBG@GL:M>=LKHMA>%,

    :G=::K>GMLMK=BGM>KOB>HK

    &///+>??.C8@/=>K:EE:BLHBGMERHO>KL>>MA>%,.

    http://digitalcommons.pace.edu/pelr/vol28/iss2/6

  • 8/6/2019 Vaccine Study

    6/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    (*"")&-#!$"'(#"$&!*$"(#!")')('!$"

    (52*$.;1A52".A6 %, :L :KM H MA> *:MBHG:EABE=AHH=:=MABLE>@BLE:MBHG MH :O> L>O>K:E H;>L MH :M> MA>

    BGK:LMK HK : G:MBHG:E BGB:MBHG KH@K: MHBGLE:M>BG=LMKR:G= MA>>=BLLBHGKHEB:;BEBMRMH >LM:;EBLA : KH@K: MH GL:M> MA> BGK>= :G= MHKHHM>L:>KO: (: HMEBG>= :G :;BMBHL :@>G=: HK O:L>:K= MA> %, MHGL:M>O:E:M>= BGKR HK =>:MAX %G BML E>@BLE:MBO> ABLMHKR

    HG@K>LL :LL>KM>= MA:M MA> KHL> H MA> KH@K: :L MH>LM:;EBLA:>=>K:EGH:EM KH@K:G=>KAB MH O:= >KLHGL B:LBER :G= BMA

    KM:BGMR :G= @>G>KHLBMRX HG@K>LL >G:= MA> LM:MM> MHGL:M> G AH A:= ;>>G BGK>= ABE> L>KOBG@ MA>;EBKH@K:K>BK>L:K>GMLHO:=GMHBE> BKLM BG MA> %, ;>HK> :GR HMA>K HKM H

    ">=>K:E E:BL BG 3:LABG@MHG HO>KL>>L MA> KH@K: *:MBHG:EABE=AHH=:

  • 8/6/2019 Vaccine Study

    7/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    M>KBEBG@BGMA>%,AH>O>K>MBMBHG>KLK>M:BGMA>KB@AMMH@H MH = >KBH= H MB> HKK>>LLBGM>G=>=MH:M>:E:K@>ER

    :=BGBLMK:MBO> KH@K: :L :G :EM>KG:MBO> MH MA> 0A>KHL>HMA>%,:LMH>LM:;EBLA:>=>K:EGH:EMX GL:MBHG KH@K: 0A> HG@K>LLBHG:E HBMM>>

    .>HKMGHM>=MA:MMA>LRLM>BLBGM>G=>=MH;>>Q>=BMBHL:G=:BKX :G= MH GL:M> K>= O:L BMAHMK>BKBG@MA>=BBM>KBG:MBHGL H KHL> H MA> LM:MM> :L MH HO>K MA>BG:=>:L H MA> >QBLMBG@ MHKM LRLM> HK O:=G7"8HKMA>K>E:MBO>ER>AH:K>BGK>=;RO:BKHGMA>HHKMGBMB>LHKK>=K>LL:G=K>LMBMMBHG :K> EBBM>= MB>Q>GLBO> :G= HM>GG:GL>K>= 5>M MK>LA:O> ;>>G=>LMKHR>=:G=HGMBG@>Q>GL>LLM;>>MX

    3A>G HG@K>LL :LL>= MA> (: MA>K> >K> L>O>K:EK>= O:L BGGA:EH:MAR:K:ERMB=BLHK=>K :G= =>:MA

    EE MA> BGKB>L HG MA> :>K>MHA:O>H0:;E>=>L=>O>GMLMA:MLMH=:RL H : BOBG@ : O:MBMBHG>KL>MMA>>Q:BK>>GMLH MA>L>=BGKB>LMA>G MA>R HE= GHM ;> K>BK>= MH EBMB@:M> :G= HE= K>BO>GL:MBHG MAKH@A :G :=BGBLMK:MBO> GH:EMX KHLL

    .::

    $..!,*+:M0A>HBMM>>7HG!G>K@R:G=H>K8:GMBL MA:MMA> L>>= H MA>GL:MBHG KH@K: MA>EH MK:GL:MA>GH:EMG:MK>HMA>K>BK>=BG=BG@L:G=MA>K>E:MBO>KM:BGMR:G=@>G>KHLBMRHMA>LRLM>ZL::K=LBEE=BO>KM:LB@GBBKHHM>GMB:EE:BGMBLKHEBMB@:MBHGX

    .:M

    .:M

    &// ,( /M:M = :L :>G=>= :M / :: +@+36+,6/ +> AMMAKL:@HOO:@BLE:MBHG=

    . ,:K:ERMB>KBH=H =:RLHLM BGKB>L>K> MHA:O>H

  • 8/6/2019 Vaccine Study

    8/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    "HK BGKB>L MA:M >K> GHM EBLM>= HG MA> 0:;E> AH>O>K>MBMBHG>KL HE= A:O> MH KHO> MA>L> BGKB>L ;:L>= HG :K>HG=>K:G H MA> >OB=>G : HK> EB>ER MA:G GHMX

    LM:G=:K=

    0A>%,BGLE:M>LO:BK>LMA:M>MBMBHG>KL;KBG@MA>BK>MBMBHGLLHE>ER:@:BGLM$$/0A>R :R GHM L> :G:KL HKA>:EMA K:KL

    0A>K:MBHG:E>HKMABLBG=LMKR:G=KH>LLBHG:EKHM>GLK> : LM:;E> KBL:HK=:;E> 0A>%, ::K=L GL:MBHG HM H : :=>K:EE:BL!B@AM/>KL:LHE>BG=>KLH:%,BL>:GMMH;>BGHK:EBMAHM K>EB:G HG MA> >=>K:E KE>L H >OB=>G :G=

    *:MBHG:E ABE=AHH= :G=>= MABL BGHK:EBMR MH ;>G>BM MA>

    .:::=//+6=9$..!,*+:M;BEEK>BK>LMA:M:>KLHGBMA:GBGKRK>LEMBG@ KH : O:K>= :M>K MA> >G:GM H MABLE>@BLE:MBHG BE> : GL:MBHG >MBMBHG :G= @H MAKH@A MA> GL:MBHGKH@K: ;>HK> KH>=BG@ BMA +8C EBMB@:MBHG :@:BGLM : :G:KX>A:LBL:==>=

    &///1/M>O>,:E:G=KBEEH)+83=2381)+--38+>398=*2C90)+--38+>381'2/3

  • 8/6/2019 Vaccine Study

    9/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    >MBMBHG>KL ;R :BG@ MA> HK LBE>K :G= E>LL />KL =H GHM L>KO> :L K>=>GM BGL;L>>GMKH>=BG@LBGLM:M>HK>=>K:EMBMBHG>KL:RK>BO>BG MA> >O>GMH:O:E:M>==>:MA:G=::QB:HGMHHK:BG:G=L>KBG@

    0A>L>GHM=LBG0A>(: :ELHKHOB=>L HK K>:LHG:;E>:MMHKG>RZL >>L:G= MBMBHGLHMA:M>MBMBHG>KL=HGHMA:O>MH:RE:R>KL

    HMHHMHKHMHMA>KH>=LH: =@>GM:LMA>RHE=A:O>MH=HBG:KK:G@>>GM

    0A>(:K>BK>LMA:M>MBMBHGL;>BE>=7GHHK>MA:G8HGMAL:M>KMA>=:M>HMA>HBKLMLRMHHK:GB>LM:MBHGHHGL>MHKH MA> LB@GBB :=BGBLMK:MBHG H MA> O:>R>:K LM:MM> H EBBM:MBHGL BL LAHKM>K MA:G :GR LM:M> MHKMLM:MM>L:G==H>LGHMKHOB=>HKMHEEBG@A>GE:BGMBL=B=GHM

    HKBGKRBMABGMA>MAK>>R>:KLM:MM>HEBBM:MBHGL

    %G>KA:LMA>HLMLB@GBBLM:MM>MA>(:K>LMKB BKLM BGMA> %,

    $..>*H:M0A>KHL>HMA>LM:MM>BLMH>LM:;EBLA:">=>K:E GH:EMZ GL:MBHGKH@K: G=>K AB MHO:=>KLHGLB:LBER:G=BMAKM:BGMR:G=@>G>KHLBMRX

    / ::ABLMA:MBGHK:MBHGL;BMM>=

    MH : L>K HK MA> =BG@ HG : >MBMBHG :R GHM ;>=BL=MH:>KLHGAHBLGHM::KMRMHMA>KH>=BG@BMAHMMA>>QK>LLKBMM>GGMHMA>>KLHGAHL;BMM>=MA>BGHK:MBHGX%GHMA>KHK=L:EEK>L>:E>=:G==HGHM;>:KMHMA>>GMG=>=:M/::: +@+36+,6/ +> AMMAKL:@HOO:@BLE:MBHG=

    &///::>

    .::

    EH>KO/>:EMA$:G/>KOL">=E">=E HG>BM:;E> MHEEBG@:G==BLKR H BGKR BGO:HK> MA>HKM H>:EL HK MA> ">=>K:E BK:KBG@MH;>A>:K=BG&//EH>KO/>:EMA$:G/>KOL*H3(">=BK+

  • 8/6/2019 Vaccine Study

    10/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    /M:KMBG@ BG GH O: HK :O:E:M>= BGKR HK =>:MA KH HG> H MA> K>G=>=O: BGKR HK =>:MA K>LEM>= KH LB=> >>K>G:OHB=:;E>>O>GMAH@AMA>O:KERK>:K>=:G=:L:K=BK>LM>LKHMA>/>LM:M>>GMH0HKML0A>/

    /K>> HKM =>=

  • 8/6/2019 Vaccine Study

    11/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    :>=BHKR>

    O::LHGHKMA>BGKR:G=:LAHBG@H:KHQB:M>M>HK:EK>E:MBHGLAB;>M>>G

    O:K>:LHGHKMABLEH>K;K=>GMA:GMA:MG>LL:KRBGK>MHM>:G==BK>MBMBHG>KL:K>GHMK>BK>=MHLAHMA>K>>>K>ERK>BK>=MHLAHMA:MMA>O:LMBHG = MA>BK BGKR X

    (52*.006;2BA6@:=BGMA>+GB;L:LBM=H>LBG:EE%,L

    : ;>>G KLB:E LBG !=:K= &>GG>KBGBMB:M>=MA>BKB=>LK>:=L>BG!G@E:G=BGMA>L/H>:K@> MA:M MA> HK:KR / HO>>GM HK O:MR:G= @:G BMA (>:0AHLHGZL M>E>OBLBHG L>G/BEE>RO/>:EMA $:G/>KOL">=E">=E

    "HK ABLMHKR H KLR :;HM O:> .H;>KM &HAGLMHG98>/7:9398 9@/7/8>= 38 3=>9KM&HAGLMHG>=

    &//#')+--38/%9?6/>>/*M>E>OBLBHG;KH:=K>BG:M>K!(5$+%!/8

    http://digitalcommons.pace.edu/pelr/vol28/iss2/6

  • 8/6/2019 Vaccine Study

    12/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    MA> E>:=BG@/ O:MR HK@:GB:MBHG 0AKH@AHM MA>E:M> ZL :G= >:KER ZL *% ;EBKB@AM MH BGHK>= GM HK O:

    KBLLHO:K:G=:K;:K:(H>"BLA>KZL;HH /$+0 %*0$!.':;HM:=O>KL>K>:,0O:LMBHG>= MA> MR

    0A> / O: BG MA> E:M> ZL %G

    HG@K>LL:G "K:G ,:EEHG> H *> &>KL>R :MM:= :G:>G=>GM MH : "HH= :G= K@ =BGBLMK:MBHG "XK>:MAHKB:MBHG;BEEK>BKBG@MA>"MH:EBLMH=K@L:G= HH=L MA:M GMBHG:EER BGMKH== >K :G= :EBM:MBO>:G:ERLBLHMA>>K;BEEE:M>K

    >OHEO>=BGMHMA>")H=>KGB:MBHG>LML ;R KHOB=BG@ =>M:BE>= BGHK:MBHG :;HM MA>BK>K MAB>KHL:E

    0AB>KHL:EA:=;>>GL>=:L:K>L>KO:MBO>BGO:L;>HBMLLMKHG@:GMB;:KB:EKH>KMB>L0A>L>HMAB>KHL:E :EEH>= O:O: :ER;R:BGEMBL>OB:EL

    *0Z(%*! %*"+ 0. AMMGOB= &:G

    />O>K:EHMA>O:KHMBG>

    &//1/8/KGB:MBHG

  • 8/6/2019 Vaccine Study

    13/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    =MAB>KHL:EBG=BAMA>KB:M>M:GL>KMLLBLKOB,$/XH$$/:G= MA>

    >KB=B:MKB=:HBGMLM:M>>GMHGMAB>KHL:EBGO:=

    ,$/:G=,MHK>G=MA:M:EEGLAHE=;>

    BGB>= :@:BGLM MA> =BL>:L>L BG=B= BG MA> K>G=>=

    BGB:MBHGL=E>#BO>GMA:MMA>KBLLHGHMO: GGHG :G= K KBL B

    :GRH>QHLK>MHMAB>KHL:EBKLM

    HGMAL H EB> >G= MH

    BGB> :EE BG:GML >O>G B MA> K MA> HBGM LM:M>>GM :K>GML H :MBLMBKK>= MA> HLLB;BEBMR MA:M >KO>EH>GM:E K>@K>LLBHGMAKH@A : GB> HKH>KO>K:E:MAHKL ;EBLA>= :G :KMB BG)!%( $5,+0$!/!/ >GMBME>=

    ?>3=7 + 89@/6 09LEMH>K@:GMHBE>E:LBML:KHG=MA>,0O:KHL:E)).GHM:;ER=H>LGHM KHL:E ;> BM OBKL>L MA:M MA> MAB>KHL:EB@AM HMA>KBL> BEE "HK : EBLM H KHL:EGML>>3.:M0:;E>

    /BG MA> E:M>

    ZL MA> O:;:M> A:L = BMA G>

    ,;$>:EMA/>KO/>ZMH$>:EMA$:G/>KOL'237/ &>+>/7/8> 90 >2/ 7/2/

    #?,63- /+6>2 &/ 90)+--38/9?)(.!

    http://digitalcommons.pace.edu/pelr/vol28/iss2/6

  • 8/6/2019 Vaccine Study

    14/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    =>O>EH>GMLBG>=B:G=LG:G=BMA:MAHKLM:BG@HLBMBHGL;HMAHK:G=:@:BGLM:HLLB;E>O:MBO>ERLBE>>LMBHGBL:MMA>

    A>:KMHMABLKH;E>0H=:R:MBLMBKXBLK>=:LR3-+8.&>+>3=>3-+6+8?+690/8>+6 3=9>K>G HK MA>GML BG LHK:GML BG O>K;:E :G= GHGO>K;:E HMRBLMKB= HK K>>MBMBO> :MM>KGL H ;>A:OBHK :G=BGM>K>LML 0A>K>:K>GHGBO>KL:EER:=;BH:K>KLL>

    =H:BGLH =B:@GHLMBL> :EHLM GH LHK:O>K> ;>A:OBHK:E KH;E>L MH >QMK>>ER AB@AGGL> BGM>K>LML :G= BKR>KLHG:EBMB>L 0A> K:G@> H :MBLMBKL BG MA> /)%HK:EER BGL :MBL .>MMZL BLHK=>K ABE=AHH=

    BLBGM>@K:MBO> BLHK=>K L>K@>KZL /RG=KH> :G= ,>KO:LBO>>O>EH>GMBLHK=>K*HM+MA>KBL>/>=,*+/X

    "HK : K>OB> H LGMBBL LHKMBG@ : HLLB;E> EBG ;>M>>GO:3:>B>E=8(+66 09=

    .:M &//3.:M

  • 8/6/2019 Vaccine Study

    15/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    >:MBLMBKBL=>BG>=HGER;R:G:@@K>@:MBHGHLRMHLMA>K>BLGH>:GBG@E=BLMBGM>>GMA>M>KL:MBLX :G= :MBLEB> LRMHLX 0ABL :KMB :>L MA>

    =BLMBGM>KLMA:MMA>HKMH">=>K:EE:BL@BO>KL:G=HMA>KLL>%MBLGHM:=BLMBG

  • 8/6/2019 Vaccine Study

    16/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    EMAH@A MA>K> A:O> ;>>G BLHE:M>= ABLMHKBKGA>GH>GHG:LBKLM=>L=;R

    3=7 /HKB@BG:E

    G BG ':GG>KZL L>KB>L

    ':GG>K BKLM GHM>=:GRHMA>LRG=KH>B:BK>= E:G@:@> LH>MBMBO> ;>A:OBHKL M

    ABL E L>KB>L :G:ERLBL :BE>= MH :L LB@GBBE:M>= LRMHL BG>=BG@ :MM>KGL:G= @:LMKHBGM>LMBG:EKH;E>L BG MA> G :G= A> :BE>= MHEHH :MHLLB;E> >GOBKHG>GM:E >QHLK>L MA:M B@AM A:O> ;>>G B=>GMBB>=G BGMA> L>KB>L A:= >Q>KB>G= GHGHKE:LB;E>>QHLK>L MH >MARE >KG G>ER:M>= LRGMA>MBBG;HMAO: L>KB>LA:=:K>GML>BMA>KBGMA>>=BLLBHGHKBG@HGO:GMLBG:@KBLBG@G@BL 3ABE>MA>>KK> :K> :GR LHKLBG +ELM>=E:QBEE ;HH MA:M @BO> MA> ARHMA>LBL

    E:LB;BEBMR

    ,BK?>3=>3-3=>?3@/98>+->*!.+/$%( +@+36+,6/ +> AMM:>=B:BM>=.@K:=LKMBL=L':GG>K+KB@,:>K=

    &// * +()/0! ).' (%(( 0$! #! +"0%/) )!..5)!%%*!*)*)!!,%!)%

    .:M

    &//3.:M

    &//3.

    +MA>K K>GM LM=B>L MA:M GHM> E:MBHGL ;>M>>G >KK>GOBKHG>GM:E MHQBGL:G=:MBLBG):KR:MA>KBG> >/HMH .H;>KM0$BME:G&9381"?>>2/&:38838190?>3=7/+@C/>+6=+8.>2/$?/=>398908-3./8-/ 0 *!.+%+(+#%! !,!.%)!*0(%/ ):KR:MA>KBG> >/HMH "-52+7G=%+D93=7 '2/+=/ 09+6!/?9B38= 98>381 >9 + 3=/+=/ 90 !/? *!.+0+%+(+#5 .:RHG= " ,:E>K >M :E#C >9 #938>&9?

  • 8/6/2019 Vaccine Study

    17/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    +G> LM GHM> MA:M MA> /)% =>BGBMBHG H :MBLMBKX BL LBBE:K HG BML : MH MA> %,ZL =>BGBMBHGL H>GA:EH:MARL>BK>L:G=L>>E:X

    >:L>=HK:;L>GMK>LHGL>MH>GOBKHG>GMK>LHG=LB:M

    :EEHGERMHEH=OHBHK:BGELMBEB

    0A>%,ZL=>LGA:EH:MARHKG>B@AM>>GHGMALH:@>:G=HE=>K BG=E>O>EH /)%ZL KB: HK HGL>M ;>HK> :@> MAK>> H :MBLMBKX0A>=B>GLBHGLH:MBLMBK:K> %,ZL =>M:BE>= =>L:L>= E>O>E H:L>=HK:;L>GM>R>HG:BER

    >;>KLHKHMA>KBG=BOB=:ELHK

    %GGMHK:;L>GMK>LHGL>LMH>QM>KG:ELMBEB=H>LGHM

    K>:BEB:K>HE>HKMABG@L

    %G HMA>K HK=L E:R> @:> B:BK>= LHE:MBHGL:G=GHGK>LHGLBO>G>LLMH>QM>KG:ELMBEB:K>GHM>=BG

    ;HMA MA> /)% :MBL :G= %, >GA:EH:MAR /)% %, =>LL GHM LGA:EH:MAR L>BK>L :G= L>>E: %G=>>= LGMBBK>LMBG@MA:M':GG>KABL>EGHM>=MA:M:;BHEH@BMBHEH@R H:MBL B@AM A:O>;>>G HO>KEHH>= %G MA> HK>HK= MH!.*. .%)(* %*"*0%(!/0%) /5*.+)! * %0/ %),(%0%+*/ "+. *!.(0$!+.5+"!$%+.':GG>KKHM>

    0A>:KERBG:GMBE>:MBLZ%MM>KG:>:L=BEM>=;R LH>MH=>KBO> BMH BMLL>K:LL>= :L:L>=H=B:@GHLMB;:L>M HK : O:KB>MR H GK>E:M>= = ;R LH> :L MA> HGER O:EB=>QE:G:MBHGLHMA:MKMA>K=HK>O>GL=

    .:MO

    &//380G=BL%:G=%% 97:+2380G=BQ%%

    http://digitalcommons.pace.edu/pelr/vol28/iss2/6

  • 8/6/2019 Vaccine Study

    18/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    EBM>K:MK> :=@>L MA:M MA> G QBLM

    (52#:;6/B@BA6@:$?L> =>LG M LB=> ;R LB=> LAH LB@GBBL

    ":BEB>L :EE>@BG@ O:= E:LBML:@:BGLMO::G=>=>K:E HKM H ">=>K:EE:BL /ER >G=>= LMA>E>LL BO> MAHL:G= >MBMBHG>KL BE>= %, H O:KHL:E :G= )).HKB>L0A>%,=>=BMHE=AHE=A>:KBG@LHGMA>L>MHM>LMMA>HKB>LBMAMAK>>M>LMLXHK>:HKRMH

    => @>G>K:E =KHBEBG@ ;> MA> LMKB>R>:K LM:MM> H EBBM:MBHGL A:=>QBK>=%G:==BMBHGLH>>MBMBHG>KLBE>=BGMA>%,:G=MA>GHO>= MA>BK L MHLM:M>:G=>=>K:EK MA>K>BK>=

    :BMBG@>KBH= MH;KBG@ E:LBML:@:BGLMO:MA>HKRHO:LB@G=>>KHK>MA>R:GM>=MHEBMB@:M>BGK>@E:K MA>R HE= >GHR KB@AML MH =BLKRHM>GMB:EERAB@AGL:MHKR:G=GBMBO>=::@>L:G=KB>L

    *HG>HMAHL>=B>GLBHGL:K>:O:BE:;E>BGMA>%,

    &///1/!KRLHG>M:E#3=77981.96/=-/8>=A3>28>/66/->?+63=+,363>3/=*&,/5$%0.5.03=7(*!0*!.+(+#5

    &//(>KHRO/>>ZMH$>:EMA$:G/>KOL*H 3( ">= E +AMMLL:MBL(>KHR=

    &///1$H>,KH=LHKO">KK:KB /!=#:

  • 8/6/2019 Vaccine Study

    19/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    +G">;K:KR/>KLHMA>">=>K:EHKMH E:BL K>E>:L>= EHG@::BM>= => BKLM+GB;LMBL,KH>=BG@M>LML0A>/>KLKE>=MA:M

    MA>K> :L GH E:LB;E> EBG ;>M>>G MA> )). O: MAK>> M>LM X >MBMBHG>KL HK MABLHKR)BEE> >=BEEH HEM>G /GR=>K :G= 5:M>L

    $:E>AKLM=>L>KO>=GHGL:MBHG0A>/>KL=B=GHMLBERLG=BL:OHK>=>MBMBHG>KL0A>RBLL>=L>=:G==>>:G>=>MBMBHG>KLZLGMBBHKB>L>Q>KMBMG>LL>L:G=MK>:MBG@ARLBK $:LMBG@L KH= MA:M MA> >=BEEH :L HG>LB=>=X MA:M MA> =H=)BEE> >=BEEH>K> @/ KHM>MA:M MA>ARLBM>>G)BEE>ZLL>O>K>:E:=B>L

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

    .:M

    /GR=>K O />:EMA $:G />KOL *H 3( :M ">= E ">; +@+36+,6/ +>AMMLLO:LH>EE/GR=>K= &///.36693(:M

    http://digitalcommons.pace.edu/pelr/vol28/iss2/6

  • 8/6/2019 Vaccine Study

    20/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    :MBL:@:BGBG=BG@GH;:LBL HKGL:MBHG 0A>L>MAK>>M>LM>MBMBHG>KL>E>=GHMMH:>:EMA>BK=>:K@BG@)).BG==:MBLBGMA>BKLML>MHM>LML

    ;HMA>=BEEH:G=$:E>AKLMEHLMHG:>:E :G=/GR=>K=B=GHM:>:E

    0A>HKMH>:ELHKMA>">=>K:EBK+D6/2? @ & HK:E :K@>GM MA> =@>L :GM>= MH GH

    A:M HE= A:>G B E:M>K LG MAB>KHL:E:MBLMA>HKR

    3A:MBEEA:>GMHMA>GZL=@>:GL>K>=ABLHG>LMBHGL:RBG@MA:MHG@K>LLKHL:EBG==:MBLMHMA>0:;E>H%GKB>L:G=LM:M>MA:MMAHL>AHA:=K>OBHLER;>>G =>GB>=GL:MBHGHE= LMBEE;>>EB@B;E>

    /BBE:KER MA> :G>E H :>EE:M> =@>L BG /.3669 @ &

    :L>=MA>>:KM>GMH&LMB+&XMH@A>LMBHGL

    0A>:>EE:M>LL>>>=GHMMHBG=MA>

    O:HKR:LBE:LB;E>:LA:=MA>/>KL

    &// )>:= O />:EMA $:G />KOL *H 3(">=E@'BG@O/>:EMA$:G/>KOL*H3(">=E):KR>KO/>:EMA

    $:G />KOL*H 3( ">= E ):K EEMAK>> L :K> :O:BE:;E> HGEBG> &// ?>3=7 /-3=398= +8. +-51>=@>L>K>:KERMKH;E>=MA:M+&A:=BGMKH==:G >Q>KM K>HKM MH K>;M >R >MBMBHG>K ;BHEH@BOB=>GBMAHM BGMKH= G=>KERBG@ E:; K>LEML HK ;HHLLH>MABG@ MA:M :EE :KMB>L :@K>>= HE= A:O> ;>>G BHLLB;E>

    >=BEEHO/>:EMA$:G/>KOL"=">=BK +@+36+,6/ +> AMMLL=BEEH>=AKLMO/>:EMA$:G/>KOL "= ">= BK +@+36+,6/ +>AMMLL$:E>AKLMBK:G=

    &//&8C./AKLMO/>:EMA $:G/>KOL "= ">= BK +@+36+,6/ +>AMM:EMA$:G/>KOL*H 3( ">= E ">; +@+36+,6/ +>AMM

  • 8/6/2019 Vaccine Study

    21/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    G=>K MA> ">=>K:E .E>L H BOBE ,KH=K> 0A>R KH;>=A>MA>K+&A:=:L>=HKMA>E:;;HHLMA>RA:=GZMHKAH+&LK>MA:MMA>>Q>KMK>HKM:LK>EB:;E>A>G+&

    =B=GZMA:O> MA>G=>KERBG@=:M: A>G MA>+& E:R>K:LLK>=MA> =@> MA:M MA> =:M: HE= A:O> K>BGHK= MA> >Q>KMZL E:@A>= :L =B= H;L>KO>KL BG MA>

    =@>L >K> LBBE:KER MKH;E>= MA:M +&:BE>= MH GHMBR >MBMBHG>KL MA:M MA>R >K> L>>BG@ MA> >Q>KMK>HKM BG MA> BKLME: :L LK>ER +& LAHE= A:O> ;>>G >EE::K>MA:MLKKBL>:L:G>GMBK>ERBG:KHKB:M>M::GM MH;>>MBMBHG>KKB>G=ER :G=GHG:=O>KL:KB:E 3ABE> MA> :>EE:M> =@>L BG ;HMA +D6/2?

    :G=/.3669=>=BG:OHKH$$/:G=:@:BGLM>MBMBHG>KLMA>R=B=LH:M>K GMBHLHK:E :K@>GM :G=MA>=@>LGHM>= BG/.3669@&MA:M+&ZL

    M>KMA>BG:E+GB;L:>:EL>K>=>=BGMA>L>KH;R:EE:>:K:GLMA>O:%,:L =0A>HKM H">=>K:E E:BLL>GMHM E>MM>KLMH:EE>MBMBHG>KLM>EEBG@MA>BGLH:GRHK=LMA:MGE>LLMA>R@> =B>K>GM MA>HKB>L :G= KHOB=> EEBG@ >Q>KML :G=>OB=>GMA>BKLHE=;>=BLBLL>=BMAHMA>:KBG@HGMA>;:LBLHMA>+GB;L@>G>K:ELML

    .

    .

    .

    .

    >=BEEHO/>:EMA$:G/>KOL"=">=BK +@+36+,6/ +> AMMLL=BEEH>=AKLMO/>:EMA$:G/>KOL "= ">= BK +@+36+,6/ +> AMMLL$:E>AKLMBK:G= 3> :@K>> BMA >MBMBHG>KL MA:MMA> @HO>KG>GML :BEK> MH KH= HK >O>G MH K>>LM MA> =HGM:MBHGG=>KERBG@ K LMBGL K>HKML BL MKH;EBG@ ;M > MABG MA:M BG MA>LGHMLMBRK>O>KL:EX

    &//MBL=:M>/>M>;>K8LEMBG@ BG MBL />K HK : /BBE:K *>KH=>O>EH>GM:EBLHK=>K 3( ">= E &ER +@+36+,6/ +>AMMLL:MBL:MBL=:M>= +.0 +" "! (%)/ #%*! 0+,!0%0%+*!./ +* $+3 0+ !%0 0$!%*! ,.+#.) +@+36+,6/ +>AMMLL:MBL!%0%*##%*!0+,.+/!/=

    http://digitalcommons.pace.edu/pelr/vol28/iss2/6

  • 8/6/2019 Vaccine Study

    22/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    (52$L>MHM>LMLBGMA>

    +GB;L MA:M HE= K A>MA>K MAB>KHL:EGM HHMA>LE:M>=M>LML%G:K>HKMK>BK>=;R HKM .E> :>= MH MA> K>LL $$/ = MA:MO:K>= $:GG:A ,HEBG@ZL>GA:EH:MAR :G= L;L>>GM =>O>EH>GM:E K>@K>LLBHG$$/ZL =>L >G :MBLEB> LRMHLX :G= :MBLX :EMAH@A MA>K>:LGH:;B@BMRMA:M$:GG:A,HEBG@BG:M

    MA> LM:MMHKR KB: HK =>HGLMK:MBG@ MA:M MA> O:= HG &ER LB@GBB= :G

    G=>KERBG@ BMHK AB=BLHL>= A>K MH=>BG>K@R >M:;HEBL :G= :GB>LM>= :L :K>@K>LLBO> >GA:EH:MAR BMA >:MK>L H :MBL L>KX0ABL=MHLH>BGM>K>LMBGMA>K>LLHG

    MA> O: KHE> H BMH @/= MA:M $$/ :B= HO>K

    &HG / ,HEBG@ >M :E /@/69:7/8>+6 %/19-298.39838+236.*3>2?>3=7&+"$%(*!.+(+#5

    &//'BK;R=?:;KB>>QKMKHMABLHKMBL:ELH:O:BE:;E>:M,HEBG@O/>:EMA$:G/>KOL *H3(">=EK%MBLGHM:;E>MA:MMABLBGBMB:EHKM >K>ER >GMBHGLMA> )). O:GL:=BGBLM>K>= MH$:GG:A ,HEBG@ BG HG> HB OBLBM A>K>:L MA> BG:E GL:MBHG =>= ;>EH BG MA> ,;EBLA>= :L> A:KM :L :L> L>L )). :L MA>KBGKBGKR

    &// #BG@>K 0:REHK '2/ %96/ 90 9@/ +8. /.3+ 38 %*!!,%!)%$+3+.,+.0!#.!!%/!/%!*!*+!.%!#+!.*)!*00$.!0!* +. $)* .%#$0/ +. $!(0$ * +. $%(.!* (HBL>'H$:;:L):KR$HEE:G=>=L

  • 8/6/2019 Vaccine Study

    23/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    BEEBHG BG =::@>L 0A> K>E>O:GM %, >;LBM> GHM>LEER AH>O>K MA:M ABE> HG> K>BO>= GL:MBHGKH MA>+GB;L$$/A:LG>O>K HMA>K BO> MAHL:G= >=A:M:=>MA>:MM>K:KMBEB>= HG MA> O>KR

    L:>>=BQ>KM:BG@MA>O>KRL:>>=B MA>#96381 :G= MH=BLBLL HG> HMA> M>LMLBMAHMMA:M>Q>KM>O>K;>BG@Q:BG>=HKM>LMBRBG@BG>KLHG BGMA> +GB;L:;HM MABL ::K>GM

  • 8/6/2019 Vaccine Study

    24/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    GL:M>= HK O:R>EBG:MBG@>GA:EHR>EBMBL !)X E>:=BG@ MH ,>KO:LBO>>O>EH>GMBLHK=>K*HM+MA>KBL>/>=:G:MBLMBK

    'BK;R

    :ELH;EBLA>=:K>LHGL>A>K>BO>=KH$$/:;HM:MBL:L: >:MK> H %,GL:M>= L $> >GMBME>= BMHGBLHKL :G= />KOBL

    =BGBLMK:MBHGH$$/ MA:M BMH>L GHM0K:

    "KHH:G:OB=$./7:BEMHH:GAKL:@HO8

    />GM"KB=:R">;K:KR,)

    0H=BK;RGRGM

    :OB=

    %GK>LHGL>MHRHKHLMK>GMBGBKR$./A:LMA>HEEHBG@

    LM:M>>GM

    0A>@HO>KG>GMA:LG>O>KGL:M>=GHKA:LBM>O>K;>>G

    HK=>K>=MHGL:M>:GR;:L>=HG:=>M>KBG:MBHGMA:M

    :MBL:L:GL:M>=

    LBGABQAB;BM>=:G>GA:EH:MARHK@>G>K:E

    ;K:BG=BL>:L>!GA:EH:MAR:R;>:=BLLBHGH:G:KK:RHLRMHLBGBK>L

    &97/-236./.099

    -97:/8=+>/937+>/6C/8.?:A3>2+?>3=793=>3-

    =C7:>97=,?>A/.989>>23=,+=3=

    .>@:K=L

    &// 1/8/KM " '>GG>=R &K :OB= 'BK;R )+--38/ 9??>3=7 /,+>/ 98>38?/= $""%*#0+* ,+/0 ">; +@+36+,6/ +>AMMABG@MHGHLMKM>GG>=RK:G==:OB=BK;RO::EMA $:G />KOL*H/E:BL(!%/">=E&ER+@+36+,6/+> AMMLL ;>EE*'/==//+6=9380=:L>A:KM

  • 8/6/2019 Vaccine Study

    25/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    :OB=H:G

    +BHHGB:EMA.>LHKL:G=/>KOBL=BGBLMK:MBHG

    0A>:MAHKL>KE>Q>=;R$$/ZL::K>GM=BLBGM>K>LMBG:G

    :LLH MA>BLL>KMA>KH:MAHK.H;>KM'K:H:==K>LL>=:"K>>=HH%GHK:MBHG %&('38

    ?>3=7 !*0.!/ %* 0%/) (+# />M ,)AMM:=O>GMK>LBG:MBL;EH@LHMA:LBL:==>="HK:G>QKMHMA>>:BEL>>:ELH'>GG>=R'BK;R=?:

    3ABE>K>

    E>@:ELM:G=:K=HL:>:LLGMBB;EBLA>=:KMBLHG O:= HG K>OB> H GL:M>= KMLLBLHEBH>:LE>LK;>EE::G=)).O:L0A>

    &//380G=BQ%%%

    &//380G=BQ%AB@HO>KG>GM:E:G=L H MA> %,GL:M>= L :L : LHK H O:E:;E> BGHK:MBHG HGO:

  • 8/6/2019 Vaccine Study

    26/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    :MAHKL A:O> BG= LGMBLML :M MA> MA> %GLMBMM> H)>=B:G=MA>%,

    . *$$B/96@521.@2@

  • 8/6/2019 Vaccine Study

    27/66

    $+((*).+ ,)

    8 (!!&*%$(&'"!&

    -(&37

    &$?:0'

    &"-5)

    6."/&374

    "5

    -56-:

    *4.&/5"-%&7&-01.&/5)"4#&&/"33&45&%&%0&4/?541&","/%8*--

    /&7&3

    $0..6/*$"5&7&3#"--:

    &%0&4/?53&410/%507&3#"-$0..6/*$"5*0/

    &*4/05

    50*-&553"*/&%&*44&-'%&4536$5*7&"/%7&3:%*''*$6-550."/"(&

    &/&&%4

    $0/45"/50/&0/0/&$"3&501305&$5)*.'

    30.*/+63*/()*.4&-'"/%05)&34=

    03&/4&/7

    &$?:0'&"-5)

    6."/&374

    "5

    -5&$

  • 8/6/2019 Vaccine Study

    28/66

    $+((*).+ ,)

    #!)%"!!'*%)* 7HE

    "4BB=4AE

    (42MH

    >540;C7

    D280;5D=2C8>

    =8=68B4GCA4?A80C4

    B748B

    14;;864A4=C0=3B>505

    40;C7

    DC0;;H34?4=34=C>=>C74AB5>A74A20A40=3=443B

    2>=BC0=

    CBD?4AE8B8>=0=30BB8BC0=24

    (748B=>=E4A10;1DCB86=BB4E4A0

    ;

    F>A3BK

    *=34AF>>3E

    (42MH>540;C7

    D=

    A4B?>=34=C=>C43C70C)A0E8BMA3B8=3820C4C70C7

    4BD5

    54A435A>=B022>A38=6C>

    A4B?>=

    34=C0A

    4=>CA4;0C43C>C74A4B83D0;B48ID

    A438B>A34AK

    (70A?=02:E

    (42MH>540;C7

    DFBC70C"460=4G7818CBB>A0;?A>1;4=0=3B>2

    80;039DBCAF78278=

    2;D34B7

    40310=68=6

    ?D;;8=674A>F=708A

    0=3B2A0C278=60CC78=6B=

    BC0=C;HA438A42C43

    4A38BAD?C8E40=3=>

    =2>